Results 161 to 170 of about 17,282 (226)

4. Pharmacologic Therapy: Antiarrhythmic Drug Therapy.

Nihon Naika Gakkai Zasshi, 2012
openaire   +2 more sources

Electrical and Mechanical Insights of Human Atrial Fibrillation [PDF]

, 2012
Sághy, László
core  

Some of the next articles are maybe not open access.

Related searches:

Antiarrhythmic drug therapy

Current Treatment Options in Cardiovascular Medicine, 2006
The use of antiarrhythmic drugs can be challenging to physicians. They are effective in treating various types of arrhythmias, yet their potential to cause adverse events, in particularly proarrhythmia, can be intimidating. When the decision to use antiarrhythmic therapy has been made, physicians are confronted with several issues: choosing the right ...
Brian R, Triola, Peter R, Kowey
openaire   +2 more sources

Therapy with Antiarrhythmic Drugs

New England Journal of Medicine, 1978
How much of what drug for whom?1 Good habits of mind are encouraged when the physician asks these questions before prescribing a drug.
P, Goldman, J A, Ingelfinger
openaire   +2 more sources

Pharmacogenetics of antiarrhythmic therapy

Expert Opinion on Pharmacotherapy, 2006
Individuals vary widely in their responses to therapy with most drugs. Indeed, responses to antiarrhythmic drugs are so highly variable that study of the underlying mechanisms has elucidated important lessons for understanding variable responses to drug therapy in general. Variability in drug response may reflect variability in the relationship between
Dawood, Darbar, Dan M, Roden
openaire   +2 more sources

Atrial Fibrillation: Antiarrhythmic Therapy

Current Problems in Cardiology, 2014
Atrial fibrillation is the most common cardiac arrhythmia and is associated with significant morbidity, mortality, and economic cost. Although the benefit of anticoagulation has been well described, control of the underlying rhythm disturbance can be achieved in various ways. Numerous therapeutic options exist and continue to be developed; however, the
Mitchell A, Psotka, Byron K, Lee
openaire   +2 more sources

Antiarrhythmic Therapy: Clinical Pharmacology Update

The Journal of Clinical Pharmacology, 1984
Abstract: Currently available antiarrhythmic agents are limited by side effects and the potential for increasing arrhythmias. In addition, drug interactions, altered disposition of drug as a result of changes in protein binding or concomitant disease processes, active metabolites, and poorly defined therapeutic ranges with great interpatient ...
R L, Woosley, I, Cerskus, D M, Roden
openaire   +2 more sources

Current antiarrhythmic therapy overview

Cardiovascular Drugs and Therapy, 1990
Cardiac arrhythmias are commonplace in the Western world and vary in their degree of seriousness from benign to life threatening. In general, arrhythmias may be managed in one of five ways: reassurance only, physical maneuvers, antiarrhythmic drugs, implantable electronic devices, and surgical or transvascular ablation.
openaire   +2 more sources

Advances in Antiarrhythmic Therapy

Veterinary Clinics of North America: Small Animal Practice, 1998
The therapy of cardiac arrhythmias in small animals can be confusing and challenging. This article reviews the current concepts of cardiac rhythm, including impulse generation, automaticity, and conduction in normal and diseased cardiac tissues. The mechanisms of arrhythmogenesis (abnormal automaticity and triggered events) and automatic modulation of ...
openaire   +2 more sources

Pharmacoeconomic Considerations in Antiarrhythmic Therapy

PharmacoEconomics, 1992
Recently, the Cardiac Arrhythmia Suppression Trial (CAST) has focused attention on the morbidity and mortality that may be associated with pharmacological antiarrhythmic therapies. While the severity and frequency of adverse effects vary among the available agents, it is uncertain whether initial therapy with one agent is preferable to that with ...
P J, Podrid, R J, Arnold, D J, Kaniecki
openaire   +2 more sources